Diabetes Mellitus, Type 2
"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Descriptor ID |
D003924
|
MeSH Number(s) |
C18.452.394.750.149 C19.246.300
|
Concept/Terms |
Diabetes Mellitus, Type 2- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Noninsulin-Dependent
- Diabetes Mellitus, Ketosis-Resistant
- Diabetes Mellitus, Ketosis Resistant
- Ketosis-Resistant Diabetes Mellitus
- Diabetes Mellitus, Non Insulin Dependent
- Diabetes Mellitus, Non-Insulin-Dependent
- Non-Insulin-Dependent Diabetes Mellitus
- Diabetes Mellitus, Stable
- Stable Diabetes Mellitus
- Diabetes Mellitus, Type II
- NIDDM
- Diabetes Mellitus, Noninsulin Dependent
- Diabetes Mellitus, Maturity-Onset
- Diabetes Mellitus, Maturity Onset
- Maturity-Onset Diabetes Mellitus
- Maturity Onset Diabetes Mellitus
- MODY
- Diabetes Mellitus, Slow-Onset
- Diabetes Mellitus, Slow Onset
- Slow-Onset Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Noninsulin-Dependent Diabetes Mellitus
- Noninsulin Dependent Diabetes Mellitus
- Maturity-Onset Diabetes
- Diabetes, Maturity-Onset
- Maturity Onset Diabetes
- Type 2 Diabetes
- Diabetes, Type 2
- Diabetes Mellitus, Adult-Onset
- Adult-Onset Diabetes Mellitus
- Diabetes Mellitus, Adult Onset
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in this website by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 1 | 2 |
2001 | 1 | 0 | 1 |
2002 | 1 | 1 | 2 |
2003 | 1 | 0 | 1 |
2004 | 2 | 1 | 3 |
2005 | 4 | 1 | 5 |
2006 | 5 | 3 | 8 |
2007 | 1 | 0 | 1 |
2008 | 3 | 0 | 3 |
2009 | 7 | 3 | 10 |
2010 | 8 | 0 | 8 |
2011 | 8 | 2 | 10 |
2012 | 4 | 0 | 4 |
2013 | 5 | 1 | 6 |
2014 | 10 | 1 | 11 |
2015 | 4 | 0 | 4 |
2016 | 10 | 1 | 11 |
2017 | 7 | 0 | 7 |
2018 | 10 | 1 | 11 |
2019 | 6 | 1 | 7 |
2020 | 12 | 2 | 14 |
2021 | 1 | 1 | 2 |
2022 | 4 | 0 | 4 |
2023 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.
-
Caudal regression syndrome type 1 with minimally invasive computed tomography and magnetic resonance imaging autopsy: a case report. J Med Case Rep. 2023 Nov 25; 17(1):491.
-
Introduction: A Multi-Pronged Approach to CKD Associated With Type 2 Diabetes. Semin Nephrol. 2023 05; 43(3):151444.
-
Association between sleep variability and time in range of glucose levels in patients with type 1 diabetes: Cross-sectional study. Sleep Health. 2023 12; 9(6):968-976.
-
Rationale and design of the linking education, produce provision, and community referrals to improve diabetes care (LINK) study. Contemp Clin Trials. 2023 07; 130:107212.
-
Management of diabetic dyslipidemia in South Asian patients: The need for individualized treatment guidelines. J Clin Lipidol. 2023 May-Jun; 17(3):313-314.
-
Alcohol use disorder as a potential risk factor for COVID-19 severity: A narrative review. Alcohol Clin Exp Res. 2022 11; 46(11):1930-1943.
-
Behind Closed Doors: A Thematic Analysis of Diabetes Community Health Worker Home Visit Content. Fam Community Health. 2022 Oct-Dec 01; 45(4):299-307.
-
The Transcription Factor YY1 Is Essential for Normal DNA Repair and Cell Cycle in Human and Mouse ?-Cells. Diabetes. 2022 08 01; 71(8):1694-1705.
-
Changes of Circulating Irisin and High-Sensitivity C-Reactive Protein Levels in Morbidly Obese Individuals with Type 2 Diabetes After Roux-en-Y Gastric Bypass. J Laparoendosc Adv Surg Tech A. 2022 Aug; 32(8):817-822.
-
GLP-1 receptor agonists and cardiovascular outcomes in patients with type 2 diabetes: Clinical evidence and best practice. J Am Assoc Nurse Pract. 2022 Feb 01; 34(2):418-440.